FLUORESCENCE IN SITU HYBRIDIZATION (FISH) ENHANCEMENT USING MICROFLUIDIC FLOW FOR AN ACCURATE, FAST AND ECONOMICAL ASSESSMENT OF HER2 STATUS IN BREAST CANCER

The fluorescence in situ hybridization (FISH) is the gold standard in human epidermal growth factor receptor 2 (HER2) status assessment in breast cancer. The dissemination of the technique is impeded by the cost of reagents and long experimental time. For overcoming these limitations, we have developed a new method for implementing FISH for HER2 assessment for tissue analysis based on microfluidic technology.


Publié dans:
20th International Conference on Miniaturized Systems for Chemistryand Life Sciences (MicroTAS 2016), 467-468
Présenté à:
Microtas 2016, Dublin, Ireland, October 9-13, 2016
Année
2016
Publisher:
RCS Publising
ISBN:
9781510834163
Laboratoires:




 Notice créée le 2017-01-24, modifiée le 2019-06-13

Preprint:
Télécharger le document
PDF

Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)